Investment Rating - The report gives a "Buy" rating for the company, Henglin Home (603661.SH) [3][11][5] Core Views - The company is a leading player in the domestic office furniture market, with revenue expected to exceed 10 billion yuan in 2024, achieving a compound annual growth rate (CAGR) of 28.6% from 2019 to 2024 [1][17] - The company is focusing on sustainable growth through both internal and external strategies, with stable demand in the office furniture sector and expansion into new markets such as PVC flooring [1][45] - The current market conditions, including a recovery in the U.S. real estate market and improvements in furniture inventory levels, are expected to enhance the company's performance [2][75] Summary by Relevant Sections Company Overview - Henglin Home is recognized as a domestic leader in office furniture, with a strong focus on ergonomic seating and a diverse product range including soft furniture and new material flooring [1][17] - The company has established a robust manufacturing system and stable overseas distribution channels, contributing to rapid business growth [1][17] Business Lines and Market Conditions - The office furniture market is experiencing steady growth, with the global market size projected to increase from $50.2 billion in 2021 to approximately $66.1 billion by 2024 [46] - The company has successfully diversified its business structure, with significant contributions from soft furniture and new material flooring, alongside its core office furniture segment [24][45] Financial Forecast and Valuation - The company is expected to see a rapid release of profits following the completion of asset impairment provisions related to its acquisition of Chuboshi, with projected net profits of 151 million, 511 million, and 648 million yuan for 2025-2027 [3][4] - The current price-to-earnings (P/E) ratios are projected to be 30, 9, and 7 for the years 2025, 2026, and 2027 respectively, indicating a favorable valuation [3][4] Growth Catalysts - Short-term catalysts include the recovery of U.S. housing demand and the completion of asset impairment provisions, while long-term catalysts involve the rapid growth of the cross-border e-commerce business and a strategic shift towards profit enhancement [10][75]

股票研究 /[Table_Date] 2026.03.11 实业新材料有望重估，化工工程不断突破 中国化学(601117) | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 韩其成(分析师) | 021-38676162 | hanqicheng@gtht.com | S0880516030004 | | 郭浩然(分析师) | 010-83939793 | guohaoran@gtht.com | S0880524020002 | | 曹有成(分析师) | 021-23185701 | caoyoucheng@gtht.com | S0880525040079 | 本报告导读： 中国化学己二腈等多品类受益化工景气改善，实业新材料资产有望重估。煤化工工 程国际领先，基础化工与石油化工占据较大的市场份额，海外业务不断突破。 投资要点： [投资建议： Table_Summary] 维持增持。维持预测 2025-2027 年 EPS1.03/1.14/1.24 元，增 速 11.0%/10.1%/8.9%，给予公司目标价 13.46 ...

公 司 研 究 深耕氨纶业，格局或向好 新乡化纤(000949) 新乡化纤首次覆盖报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 刘威(分析师) | 0755-82764281 | liuwei7@gtht.com | S0880525040100 | | 沈唯(分析师) | 0755-23976795 | shenwei2@gtht.com | S0880523080006 | 本报告导读： 公司是氨纶及生物质纤维素长丝核心企业，随着氨纶格局或改善，氨纶价格有望向 上。 投资要点： | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 7,379 | 7,366 | 7,627 | 7,890 | 9,340 | | (+/-)% | 1.4% | -0.2% | 3.5% | 3.4% | 18.4% | | 净利润(归母) | -42 ...

电力设备/电池 宁德时代（300750.SZ） 量利齐升，盈利韧性再超预期 2026 年 03 月 11 日 投资评级：买入（维持） | 日期 | 2026/3/10 | | --- | --- | | 当前股价(元) | 376.30 | | 一年最高最低(元) | 424.36/209.11 | | 总市值(亿元) | 17,173.84 | | 流通市值(亿元) | 16,017.73 | | 总股本(亿股) | 45.64 | | 流通股本(亿股) | 42.57 | | 近 3 个月换手率(%) | 39.64 | 股价走势图 数据来源：聚源 -24% 0% 24% 48% 72% 2025-03 2025-07 2025-11 宁德时代 沪深300 相关研究报告 《与江汽集团、易控智驾签署战略合 作协议，下游多场景放量可期—公司 信息更新报告》-2025.10.27 殷晟路（分析师） 王嘉懿（分析师） yinshenglu@kysec.cn wangjiayi@kysec.cn 证书编号：S0790525060004 2025 年公司实现归母净利润 722 亿元，同比增长 42% 公司发布 202 ...

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [4]. Core Insights - The company has launched a stock incentive plan for its CDMO business core management and technical staff, which is expected to drive growth. The plan involves granting 7.597 million stock options at a price of 13.38 RMB, with performance targets set for net profit growth from 2026 to 2029 [4]. - The CDMO business has become the largest revenue contributor, with a revenue of 1.69 billion RMB in the first three quarters of 2025, representing a year-over-year growth of 20%. The gross margin for this segment is 44.5%, up by 3.7 percentage points [7]. - The company anticipates a recovery in overall performance, with expected net profits of 909 million RMB in 2025, 1.052 billion RMB in 2026, and 1.233 billion RMB in 2027, reflecting a year-over-year growth of 15.76% and 17.20% in the following years [6][7]. Financial Summary - The company’s projected net profit for 2025 is 909 million RMB, with an EPS of 0.78 RMB, and a P/E ratio of 22.91. For 2026, the net profit is expected to rise to 1.052 billion RMB, with an EPS of 0.91 RMB and a P/E ratio of 19.79. By 2027, the net profit is projected to reach 1.233 billion RMB, with an EPS of 1.06 RMB and a P/E ratio of 16.89 [6][10]. - The company’s revenue is expected to increase from 10.472 billion RMB in 2025 to 11.347 billion RMB in 2026, and further to 12.047 billion RMB in 2027 [10].

Investment Rating - The report has downgraded the investment rating to "Outperform" [2][6] Core Insights - The company achieved a revenue of 1.058 billion yuan in 2025, representing a year-on-year growth of 21.8%, and a net profit attributable to the parent company of 237 million yuan, up 33.9% year-on-year [2][5] - The diabetes and hypertension segments showed stable growth, with diabetes revenue increasing by 18.2% and hypertension revenue by 28.3% in 2025 [3][4] - The company has a robust pipeline with over 30 products in development, including DYX116, which is nearing completion of its Phase I clinical trials for diabetes treatment [4][6] Financial Summary - Revenue projections for 2026-2028 are adjusted to 1.183 billion yuan, 1.308 billion yuan, and 1.435 billion yuan, respectively, with corresponding net profits of 238 million yuan, 252 million yuan, and 264 million yuan [5][7] - The gross margin is expected to decline slightly from 84.1% in 2025 to 81.8% by 2028, reflecting potential pressures from future product pricing and R&D investments [5][8] - The earnings per share (EPS) forecast for 2026-2028 is set at 2.03 yuan, 2.15 yuan, and 2.25 yuan, with price-to-earnings (P/E) ratios of 16.9, 16.0, and 15.3, respectively [2][5]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of 96.25 yuan [5][22]. Core Insights - The company is a leading domestic supplier of aerospace engine ring forgings, benefiting from the global upgrade of aviation engines and the increasing demand for commercial aerospace and gas turbines, which is expected to enter a new performance release cycle [2][11]. - The company has a complete product matrix covering aerospace engine forgings, aerospace forgings, and gas turbine forgings, solidifying its position as a core supplier in high-end equipment scenarios [11][24]. - The global aerospace industry is upgrading, with continuous recovery in military and commercial aviation demand, and the acceleration of domestic engine localization, leading to sustained release of high-end forging demand [11][24]. - The company has established a comprehensive digital manufacturing system and possesses key core technologies, creating strong competitive barriers [11][24]. Financial Summary - Total revenue is projected to reach 2,104 million yuan in 2023, with a growth rate of 44.7%, followed by a decline of 14.2% in 2024, and then a recovery with growth rates of 17.1%, 38.6%, and 33.3% in the subsequent years [4][12]. - Net profit attributable to the parent company is expected to be 186 million yuan in 2023, with a slight increase of 1.2%, and projected to grow significantly to 444 million yuan by 2027 [4][12]. - Earnings per share (EPS) is forecasted to be 0.97 yuan in 2023, increasing to 2.33 yuan by 2027 [4][12]. Business Segmentation - The company's revenue is primarily driven by aerospace forgings, which are expected to generate 1,501 million yuan in 2023, accounting for a significant portion of total revenue [17][43]. - Gas turbine forgings are anticipated to be a core growth engine, with revenue expected to grow from 166.20 million yuan in 2023 to 855.16 million yuan by 2027, reflecting a compound annual growth rate of 40% [17][43]. - Aerospace forgings are projected to maintain a high gross margin, while gas turbine forgings are expected to recover gradually [44][43]. Industry Demand Expansion - The demand for aerospace engine ring forgings is expected to strengthen due to the global upgrade of aviation engines and the increasing need for domestic commercial aircraft engines [46][55]. - The domestic commercial aircraft engine market is anticipated to release significant growth potential, particularly with the scale delivery of the C919 and the localization of commercial aircraft engines [55][54]. - The integration of military and civilian applications is expected to expand the market for gas turbine forgings, with various application scenarios emerging [11][24].

公司研究 [Table_ReportType] 公司点评报告 [伟Ta星bl股e_份Sto(c0k0A2n0d0Ra3n.kS]Z) [姜Ta文b镪le_新Au消th费o行r]业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 刘田田 纺织服饰行业联席首席分析师 执业编号：S1500525120001 邮箱：liutiantian@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 证券研究报告 [Table_Title] 伟星股份：收入稳健修复，利润端短期承压 [Table_ReportDate] 2026 年 3 月 11 日 投资评级 上次评级 事件：公司发布 2025 年业绩快报，全年实现营业总收入 47.87 亿元，同 比增长 2.41%；归母净利润为 6.42 亿元，同比下降 8.38%；扣非净利润 6.26 亿元，同比下降 9.09%。单季度看，2025 年 Q4 营业收入 11.54 亿 元，同比增长 5.5%，环比提速明 ...

公司深度研究 | 中国能建 能源建设领军者，绿色燃料打开空间 中国能建（601868.SH）首次覆盖报告 【核心结论】公司是能源建设龙头，看好未来投资运营业务带来业绩增量， 我们给予公司 2026 年 18 倍 PE，对应目标价为 3.96 元/股，首次覆盖，给 予"买入"评级。 国家能源电力建设排头兵，新能源投资运营占比持续提升。1）公司控股股 东为能建集团（持股 45.21%），实控人为国资委，国有资本为绝对主导，A+H 股两地上市；公司以能源电力建设为核心主业形成完整产业链服务能力，在 火电、水电、核电及清洁能源输电通道工程等设计施工领域市占率领先。2） 业务结构持续优化，25 全年新签订单中境外订单同比+9.1%、工程建设中新 能源/城市建设/综合交通订单同比+6.7%/+20.2%/+52.8%。3）新能源业务向 "投建营一体化+储能+氢能"纵深推进：公司控股新能源并网项目装机容量 从 22 年末的 498.7 万千瓦提升至 25 年半年末的 1602.73 万千瓦，新能源投 建营业务毛利率显著高于工程承包，叠加占比持续提升，推动利润结构优化。 构建氢能一体化发展格局，快速抢占市场。公司在吉林松原、 ...

北交所信息更新 2025 完成五新重工利润并表，预计全年归母净利升至 1.99 亿元 ——北交所信息更新 2026 年 03 月 11 日 投资评级：买入（维持） | 日期 | 2026/3/10 | | --- | --- | | 当前股价(元) | 42.85 | | 一年最高最低(元) | 98.99/25.03 | | 总市值(亿元) | 92.94 | | 流通市值(亿元) | 37.28 | | 总股本(亿股) | 2.17 | | 流通股本(亿股) | 0.87 | | 近 3 个月换手率(%) | 112.17 | 北交所研究团队 诸海滨（分析师） 余中天（分析师） zhuhaibin@kysec.cn 证书编号：S0790522080007 yuzhongtian@kysec.cn 证书编号：S0790525050003 2025 全年预计营收 14.01 亿元，归母净利润 1.99 亿元，维持"买入"评级 五新隧装公布 2025 业绩快报。五新隧装于 2025 年 12 月 25 日完成重大资产重组 标的公司资产过户手续，2025 年合并资产负债表新增湖南中铁五新重工有限公 司和怀化市兴中 ...